- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Eosinophil percentage elevation as a prognostic factor for overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
September 29, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
September 28, 2016
Renal Cell Carcinoma Metastasized to Pagetic Bone
September 28, 2016
Systematic review of renal carcinoma prognostic factors
September 28, 2016
How Did We Obtain Complete Remission in Patients Who Had Metastatic Renal Cancer in the Era of Targeted Therapies?
September 27, 2016
Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy
September 26, 2016
Overexpression of functional SLC6A3 in clear cell renal cell carcinoma
September 26, 2016
The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma
September 26, 2016
Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings
September 21, 2016
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"
September 21, 2016
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma
September 20, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma
September 20, 2016
Cytomorphology of clear cell papillary renal cell carcinoma
September 19, 2016
Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma
September 16, 2016
Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy
September 16, 2016